Abercrombie Fitch Could Surge, Analyst Sees Upside
A Needham note argues that Abercrombie & Fitch could surge as stabilizing sales, strong Hollister growth and aggressi...
This tag page curates the latest Analyst Upgrades articles, including Walmart, fintech stocks, and Oracle's insights. Learn how these moves affect risk and opportunities for your portfolio.
10 articlesA Needham note argues that Abercrombie & Fitch could surge as stabilizing sales, strong Hollister growth and aggressi...
A mid-week move in Constellation Energy shares sparked questions about momentum and fundamentals. This piece breaks d...
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
Raymond James lifts Valero's price target to $290, arguing sustained refining margins and a structural advantage coul...
Ciena shares surged on Monday thanks to upbeat analyst revisions and higher price targets. This article breaks down w...
A Tuesday uptick in Edgewise Therapeutics stock topped the market, driven by an upbeat price target from a major bank...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
An Oppenheimer upgrade follows Oracle’s dramatic price drop, suggesting patient investors could access a premier grow...
In a day when many markets drifted lower, walmart stock topped market thanks to upbeat targets and steady demand. Thi...